290 related articles for article (PubMed ID: 30801954)
1. Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-κB-modulated tumor progression in bladder cancer in vitro and in vivo.
Chiang CH; Chung JG; Hsu FT
Environ Toxicol; 2019 Jun; 34(6):679-688. PubMed ID: 30801954
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
[TBL] [Abstract][Full Text] [Related]
3. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells.
Tsai JJ; Pan PJ; Hsu FT
Oncol Rep; 2017 Feb; 37(2):1036-1044. PubMed ID: 28000898
[TBL] [Abstract][Full Text] [Related]
4. Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice.
Weng MC; Wang MH; Tsai JJ; Kuo YC; Liu YC; Hsu FT; Wang HE
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29535278
[TBL] [Abstract][Full Text] [Related]
5. Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo.
Wu CH; Hsu FT; Chao TL; Lee YH; Kuo YC
Biomed Pharmacother; 2022 Jan; 145():112437. PubMed ID: 34864311
[TBL] [Abstract][Full Text] [Related]
6. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
Liu YC; Tsai JJ; Weng YS; Hsu FT
Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
[TBL] [Abstract][Full Text] [Related]
7. Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-ĸB-modulated Survival and Invasion Potential in Bladder Cancer.
Liu YC; Lin KH; Hsieh JH; Chung JG; Tan ZL; Hsu FT; Chiang CH
In Vivo; 2019; 33(6):1865-1877. PubMed ID: 31662514
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.
Chen WT; Hsu FT; Liu YC; Chen CH; Hsu LC; Lin SS
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754643
[TBL] [Abstract][Full Text] [Related]
9. Effect of Regorafenib on P2X7 Receptor Expression and Different Oncogenic Signaling Pathways in a Human Breast Cancer Cell Line: A Potential of New Insight of the Antitumor Effects of Regorafenib.
Salahuddin MM; Omran GA; Helmy MW; Houssen ME
Curr Issues Mol Biol; 2021 Dec; 43(3):2199-2209. PubMed ID: 34940128
[TBL] [Abstract][Full Text] [Related]
10. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
11. Regorafenib Induces Apoptosis and Inhibits Metastatic Potential of Human Bladder Carcinoma Cells.
Hsu FT; Sun CC; Wu CH; Lee YJ; Chiang CH; Wang WS
Anticancer Res; 2017 Sep; 37(9):4919-4926. PubMed ID: 28870913
[TBL] [Abstract][Full Text] [Related]
12. Lenvatinib Inhibits AKT/NF-κB Signaling and Induces Apoptosis Through Extrinsic/Intrinsic Pathways in Non-small Cell Lung Cancer.
Liu YC; Huang BH; Chung JG; Liu WL; Hsu FT; Lin SS
Anticancer Res; 2021 Jan; 41(1):123-130. PubMed ID: 33419805
[TBL] [Abstract][Full Text] [Related]
13. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways.
Maroufi NF; Vahedian V; Akbarzadeh M; Mohammadian M; Zahedi M; Isazadeh A; Pouremamali F; Taefehshokr S; Heidari M; Rashidi M; Nouri M
Breast Cancer; 2020 Jul; 27(4):613-620. PubMed ID: 32026267
[TBL] [Abstract][Full Text] [Related]
14. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts.
Kefaloyianni E; Gaitanaki C; Beis I
Cell Signal; 2006 Dec; 18(12):2238-51. PubMed ID: 16806820
[TBL] [Abstract][Full Text] [Related]
15. Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo.
Su CM; Weng YS; Kuan LY; Chen JH; Hsu FT
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429376
[TBL] [Abstract][Full Text] [Related]
16. Activation of p38 mitogen-activated protein kinase and nuclear factor-kappaB in tumour necrosis factor-induced eotaxin release of human eosinophils.
Wong CK; Zhang JP; Ip WK; Lam CW
Clin Exp Immunol; 2002 Jun; 128(3):483-9. PubMed ID: 12067303
[TBL] [Abstract][Full Text] [Related]
17. The p38 mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor in osteoblasts.
Chae HJ; Chae SW; Chin HY; Bang BG; Cho SB; Han KS; Kim SC; Tae KC; Lee KH; Kim DE; Im MK; Lee SJ; Chang JY; Lee YM; Kim HM; Kim HH; Lee ZH; Kim HR
Bone; 2001 Jan; 28(1):45-53. PubMed ID: 11165942
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway.
Je JH; Lee JY; Jung KJ; Sung B; Go EK; Yu BP; Chung HY
FEBS Lett; 2004 May; 566(1-3):183-9. PubMed ID: 15147892
[TBL] [Abstract][Full Text] [Related]
19. Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production.
Yamakawa T; Eguchi S; Matsumoto T; Yamakawa Y; Numaguchi K; Miyata I; Reynolds CM; Motley ED; Inagami T
Endocrinology; 1999 Aug; 140(8):3562-72. PubMed ID: 10433212
[TBL] [Abstract][Full Text] [Related]
20. Diosgenin, a plant steroid, induces apoptosis in COX-2 deficient K562 cells with activation of the p38 MAP kinase signalling and inhibition of NF-kappaB binding.
Liagre B; Bertrand J; Leger DY; Beneytout JL
Int J Mol Med; 2005 Dec; 16(6):1095-101. PubMed ID: 16273292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
